Peer Dar zitzer

Professor

Montefiore Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Science Medical Science professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peer Dar Zitzer is a Professor at Montefiore Hospital and Medical Center in the United States. His research primarily focuses on noninvasive prenatal screening and the implications of cell-free DNA screening in obstetrical and genetic outcomes. Recent articles highlight his work on prenatal cfDNA screening for sex chromosomes and its performance in various patient risk categories. His contributions are significant in enhancing clinical care strategies related to prenatal diagnostics.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Collaborators (4)

Georgios Doulaveris

Assistant Professor

Albert Einstein College of Medicine

UNITED STATES

View details

Luciana Vieira

Assistant professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Fergal D. Malone

Professor and Maternal Fetal Medicine Specialist

IRELAND

View details

Ylva Carlsson

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peer Dar zitzer

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Performance of prenatal cfDNA screening for sex chromosomes.

Non-reportable cell free DNA results in high-risk versus low-risk patients.

Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening results.

Evaluating Expanded Noninvasive Prenatal Screening.

Primary cell-free DNA screening or contingent screening for the common trisomies: a response.

Performance of noninvasive prenatal screening for 22q11.2 deletion syndrome in the SMART study.

Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.

Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome.

Impact of introducing cell-free DNA screening into clinical care on first trimester ultrasound.

Prenatally diagnosed vasa previa: association with adverse obstetrical and neonatal outcomes.

Collaborators (4)

Georgios Doulaveris

Luciana Vieira

Fergal D. Malone

Ylva Carlsson

Make your next move.